Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tiberghien

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|March 4, 2000
Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinaseF Aubin, J Y Cahn, C Ferrand, et al.
The Journal of Rheumatology|July 16, 1999
HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritisE Toussirot, B Auge, P Tiberghien, et al.
Bone Marrow Transplantation|January 1, 1991
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia--a European survey. EBMT Working Party on ABMTP Hervé, M Labopin, E Plouvier, et al.
Blood|October 1, 1990
Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recoveryP Tiberghien, D L Longo, J W Wine, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 1, 2014
[Hepatitis E virus: Blood transfusion implications]P Gallian, Y Piquet, A Assal, et al.
Cell and Tissue Research|November 17, 2006
Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a moleculeF Gindraux, Z Selmani, L Obert, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2008
[Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?]P Saas, F Bonnefoy, F Kleinclauss, et al.
Hematology and Cell Therapy|April 1, 1996
Gene transfer applied to the modulation of alloreactivityP Tiberghien, J Y Cahn, E Contassot, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 25, 2019
Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patientsC Martinaud, P Tiberghien, S Bégué, et al.
Tissue Antigens|September 17, 1999
HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritisE Toussirot, I Auger, C Roudier, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|March 4, 2000
Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinaseF Aubin, J Y Cahn, C Ferrand, et al.
The Journal of Rheumatology|July 16, 1999
HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritisE Toussirot, B Auge, P Tiberghien, et al.
Bone Marrow Transplantation|January 1, 1991
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia--a European survey. EBMT Working Party on ABMTP Hervé, M Labopin, E Plouvier, et al.
Blood|October 1, 1990
Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recoveryP Tiberghien, D L Longo, J W Wine, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 1, 2014
[Hepatitis E virus: Blood transfusion implications]P Gallian, Y Piquet, A Assal, et al.
Cell and Tissue Research|November 17, 2006
Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a moleculeF Gindraux, Z Selmani, L Obert, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 6, 2008
[Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?]P Saas, F Bonnefoy, F Kleinclauss, et al.
Hematology and Cell Therapy|April 1, 1996
Gene transfer applied to the modulation of alloreactivityP Tiberghien, J Y Cahn, E Contassot, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 25, 2019
Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patientsC Martinaud, P Tiberghien, S Bégué, et al.
Tissue Antigens|September 17, 1999
HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritisE Toussirot, I Auger, C Roudier, et al.
Pageof 15